PTC Therapeutics | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Acadia Pharmaceuticals USD 32.37M 13.08M 2025-06
Alnylam Pharmaceuticals USD -16199000 34.28M 2025-06
Amgen USD 2.66B 1.37B 2025-06
Biogen USD 851.8M 540.6M 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Cytokinetics USD -111506000 44.12M 2025-06
Daiichi Sankyo JPY 96.71B 13.1B 2025-06
Gilead Sciences USD 2.7B 467M 2025-06
Incyte USD 310.82M 105.66M 2025-06
Ionis Pharmaceuticals USD 139.84M 285.84M 2025-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Novartis USD 4.86B 201M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
PTC Therapeutics USD -34858000 1.01B 2025-06
Roche Holding CHF 4.39B 1.04B 2024-12
Sarepta Therapeutics USD 115.58M 415.96M 2025-06
TG Therapeutics USD 34.84M 26.22M 2025-06
Ultragenyx Pharmaceutical USD -193567000 50.63M 2025-06
Vertex Pharmaceuticals USD 1.15B 123.1M 2025-06
Xencor USD -33172000 10.01M 2025-06


PTC Therapeutics Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.